Open Access. Powered by Scholars. Published by Universities.®

Life Sciences Commons

Open Access. Powered by Scholars. Published by Universities.®

Journal

Kansas Agricultural Experiment Station Research Reports

Veterinary Medicine

Liver abscesses

Articles 1 - 2 of 2

Full-Text Articles in Life Sciences

Intermittent Feeding Of Tylan Reduces Use Of In-Feed Antibiotics While Still Controlling Incidence Of Liver Abscesses In Finishing Steers, H. C. Muller, R. G. Amachawadi, H. M. Scott, J. S. Drouillard Jan 2017

Intermittent Feeding Of Tylan Reduces Use Of In-Feed Antibiotics While Still Controlling Incidence Of Liver Abscesses In Finishing Steers, H. C. Muller, R. G. Amachawadi, H. M. Scott, J. S. Drouillard

Kansas Agricultural Experiment Station Research Reports

Liver abscesses are a cause of concern for many feedlots across the country as they lead to a decrease in feedlot performance of finishing cattle as well as a decrease in the final carcass value. Loss in carcass value is due to not only the abscessed liver being condemned, but also due to trim loss associated with the condemned liver. The macrolide drug tylosin phosphate is the drug of choice for metaphylactic treatment of liver abscesses in feedlot cattle. The Food and Drug Administration approved the drug for over-the-counter use, however, from January 2017 all medically important (used in human …


Antioxidant Feeding Does Not Impact Incidence Or Severity Of Liver Abscesses, H. C. Muller, C. L. Van Bibber-Krueger, J. S. Drouillard Jan 2017

Antioxidant Feeding Does Not Impact Incidence Or Severity Of Liver Abscesses, H. C. Muller, C. L. Van Bibber-Krueger, J. S. Drouillard

Kansas Agricultural Experiment Station Research Reports

Liver abscesses are a large source of economic loss in feedlot cattle. Not only do liver abscesses lead to a decrease in feedlot performance, but these livers are condemned in the abattoir and can also lead to a further decrease in carcass value due to trim loss. Tylosin phosphate is a metaphylactic macrolide drug that effectively decreases the occurrence of liver abscesses. The drug is approved by the Food and Drug Administration for over-the-counter use. However, in January 2017 the FDA will require a veterinary feed directive for medically important antibiotics (antibiotics that are used in human health) used in …